ArticleTuberculosis (Edinburgh, Scotland)2022

Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria.

Prem Shankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.